Literature DB >> 7007381

NADH inhibition and NAD activation of Escherichia coli lipoamide dehydrogenase catalyzing the NADH-lipoamide reaction.

K D Wilkinson, C H Williams.   

Abstract

A unique form of inhibition by NADH and partial reversal by NAD+ has been demonstrated with Escherichia coli lipoamide dehydrogenase. Substrate inhibition by NADH is consistent with its reduction of the active two-electron reduced enzyme intermediate to the inactive four-electron reduced form. NAD+ partially overcomes this inhibition by mass action reversal of this reduction. NAD+ activation is only partial since the presence of both NAD+ and NADH forces the accumulation of two binary enzyme-pyridine nucleotide complexes. These are intermediates in the two-electron to four-electron reduction of the enzyme and thus are not on the catalytic pathway. NAD+ is also shown to inhibit by binding to the oxidized enzyme to give a dead-end complex. From the steady state rate equations, it is apparent that the degree of inhibition will depend on the oxidation-reduction potential for two- to four-electron reduction of the enzyme. Thus, the wide variation in the severity of NADH inhibition between the E. coli and pig heart enzymes is explained by quantitative differences in the basic lipoamide dehydrogenase mechanism. A possible physiological role for this type of inhibition as a mechanism of control in E. coli is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7007381

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Catabolism of branched-chain alpha-keto acids in Enterococcus faecalis: the bkd gene cluster, enzymes, and metabolic route.

Authors:  D E Ward; R P Ross; C C van der Weijden; J L Snoep; A Claiborne
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  A pH-dependent kinetic model of dihydrolipoamide dehydrogenase from multiple organisms.

Authors:  Michael A Moxley; Daniel A Beard; Jason N Bazil
Journal:  Biophys J       Date:  2014-12-16       Impact factor: 4.033

3.  Global Kinetic Analysis of Mammalian E3 Reveals pH-dependent NAD+/NADH Regulation, Physiological Kinetic Reversibility, and Catalytic Optimum.

Authors:  Michael A Moxley; Daniel A Beard; Jason N Bazil
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

4.  Dihydrolipoamide dehydrogenase mutation alters the NADH sensitivity of pyruvate dehydrogenase complex of Escherichia coli K-12.

Authors:  Youngnyun Kim; L O Ingram; K T Shanmugam
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

5.  Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain.

Authors:  Liang-Jun Yan; Nopporn Thangthaeng; Michael J Forster
Journal:  Mech Ageing Dev       Date:  2008-02-06       Impact factor: 5.432

6.  Detailed evaluation of pyruvate dehydrogenase complex inhibition in simulated exercise conditions.

Authors:  Bodhi A Jelinek; Michael A Moxley
Journal:  Biophys J       Date:  2021-01-28       Impact factor: 4.033

7.  Engineering acetyl coenzyme A supply: functional expression of a bacterial pyruvate dehydrogenase complex in the cytosol of Saccharomyces cerevisiae.

Authors:  Barbara U Kozak; Harmen M van Rossum; Marijke A H Luttik; Michiel Akeroyd; Kirsten R Benjamin; Liang Wu; Simon de Vries; Jean-Marc Daran; Jack T Pronk; Antonius J A van Maris
Journal:  mBio       Date:  2014-10-21       Impact factor: 7.867

Review 8.  Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications.

Authors:  Jinzi Wu; Zhen Jin; Hong Zheng; Liang-Jun Yan
Journal:  Diabetes Metab Syndr Obes       Date:  2016-05-10       Impact factor: 3.168

9.  The DEAD-box RNA helicase CshA is required for fatty acid homeostasis in Staphylococcus aureus.

Authors:  Vanessa Khemici; Julien Prados; Bianca Petrignani; Benjamin Di Nolfi; Elodie Bergé; Caroline Manzano; Caroline Giraud; Patrick Linder
Journal:  PLoS Genet       Date:  2020-07-30       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.